Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1/2a study.
暂无分享,去创建一个
D. Kondziolka | L. Lunsford | L. Wechsler | G. Steinberg | C. Case | Jeremiah N. Johnson | N. Schwartz | A. Kim | M. Mcgrogan | D. Bates | E. Yankee | Julia B. Billigen | Maria L. Coburn | Bill King | Gene Poggio